^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    One-Step Nucleic Acid Amplification (OSNA) Assay

    Company:
    Sysmex Corp
    Type:
    Other Approval
    Related tests:
    Details
    Evidence

    News

    13d
    Analysis of PIK3CA mutations in the lysate of sentinel lymph nodes in patients with early breast cancer. (PubMed, Front Oncol)
    Assessment of tumor-derived mutated DNA in SNs may be a useful technique to detect SN metastasis, as confirmed by ddPCR analysis. Further analyses, using data from a greater number of patients, are necessary to determine whether the results of whole-genome and whole-exome sequencing can be applied to other genes.
    Journal
    |
    PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • KRT19 (Keratin 19)
    |
    PIK3CA mutation
    |
    One-Step Nucleic Acid Amplification (OSNA) Assay
    1m
    One-step nucleic acid amplification versus ultra-staging to detect sentinel lymph node metastasis in endometrial cancer: a randomized, multi-center, controlled trial (SENT-OSNA Trial). (PubMed, Int J Gynecol Cancer)
    Four years of accrual, with estimated results to be presented in 2029. The trial is registered at ClinicalTrials.gov (NCT06935305).
    Journal
    |
    One-Step Nucleic Acid Amplification (OSNA) Assay